FDA approves remdesivir for hospitalized COVID-19 patients
The Food and Drug Administration on Thursday approved the antiviral drug remdesivir as a treatment for patients with COVID-19 who require hospitalization.
FDA approves remdesivir for hospitalized COVID-19 patients
USATODAY.com
0 shares
3 views
You might like
Related news coverage
New COVID-19 Cases And Hospitalizations Up; Deaths May Follow
Newsy
Watch VideoHospitals are bracing for another surge of COVID-19 patients. In parts of Texas, COVID-19 hospitalizations have roughly..
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
-
NA Proactive news snapshot: Esports Entertainment Group, CytoDyn, ImagineAR, GlobeX Data …
Proactive Investors
-
Biotech Stocks Facing FDA Decision In November 2020
RTTNews
Advertisement
More coverage
Remdesivir Receives Approval from FDA, First Among for COVID-19 Treatment
HNGN
The Food and Drug Administration authorized Remdesivir for the treatment of patients over the age of 12 who have been admitted with..
FDA Approves Antiviral Remdesivir As COVID-19 Treatment
Eurasia Review